Cancer Family
Endocrine Neoplasm
CI-CAN-00000015Explore in graph →
Non-malignant764 active trials16 approved drugs64 evidence items
- NCIt
- C3010
Loading cancer entity…
Cancer Family
CI-CAN-00000015Explore in graph →
Clinical trials
2,725 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00182689 | Sorafenib in Treating Patients With Extensive Stage Small Cell Lung Cancer | completed | Phase 2 | 89 | National Cancer Institute (NCI)NIH | 1 | May 21, 2014 | clinicaltrials |
| NCT00066742 | Tirapazamine Combined With Chemo and RT in Limited-Stage Small Cell Lung Cancer | completed | Phase 2 | 72 | National Cancer Institute (NCI)NIH | 1 | May 15, 2014 | clinicaltrials |
| NCT00079040 |
| Cisplatin, Etoposide, and Bevacizumab in Treating Patients With Previously Untreated Extensive Stage Small Cell Lung Cancer |
| completed |
| Phase 2 |
| 65 |
| National Cancer Institute (NCI)NIH |
| 1 |
| May 14, 2014 |
| clinicaltrials |
| NCT00773955 | R-(-)-Gossypol Acetic Acid in Treating Patients With Recurrent Extensive-Stage Small Cell Lung Cancer | completed | Phase 2 | 15 | National Cancer Institute (NCI)NIH | 1 | May 12, 2014 | clinicaltrials |
| NCT00848016 | Gossypol Acetic Acid in Treating Patients With Recurrent, Metastatic, or Primary Adrenocortical Cancer That Cannot Be Removed By Surgery | completed | Phase 2 | 29 | National Cancer Institute (NCI)NIH | 1 | May 7, 2014 | clinicaltrials |
| NCT00616109 | Sunitinib Maintenance Therapy After Induction Platinum-Based Chemotherapy in Patients With ES-SCLC | completed | Phase 2 | 16 | University of Michigan Rogel Cancer CenterOTHER | 1 | Apr 21, 2014 | clinicaltrials |
| NCT00086827 | Romidepsin in Treating Patients With Relapsed Small Cell Lung Cancer | completed | Phase 2 | 36 | National Cancer Institute (NCI)NIH | 1 | Apr 10, 2014 | clinicaltrials |
| NCT00052949 | Imatinib Mesylate in Treating Patients With Recurrent Small Cell Lung Cancer | completed | Phase 2 | 91 | National Cancer Institute (NCI)NIH | 1 | Oct 8, 2013 | clinicaltrials |
| NCT00602082 | Capecitabine and Streptozocin With or Without Cisplatin in Treating Patients With Unresectable or Metastatic Neuroendocrine Tumors | completed | Phase 2 | 84 | Cambridge University Hospitals NHS Foundation TrustOTHER | 1 | Aug 7, 2013 | clinicaltrials |
| NCT00607113 | Avastin (Bevacizumab) and RAD001 (Everolimus) in Advanced Low or Intermediate Grade Neuroendocrine Carcinoma | completed | Phase 2 | 41 | M.D. Anderson Cancer CenterOTHER | 1 | Jul 18, 2013 | clinicaltrials |
| NCT00002608 | Combination Chemotherapy and Tamoxifen in Treating Patients With Solid Tumors | completed | Phase 2 | 30 | Ottawa Regional Cancer CentreOTHER | 1 | Jul 10, 2013 | clinicaltrials |
| NCT00004922 | Irinotecan in Treating Patients With Advanced Neuroendocrine Tumors | completed | Phase 2 | — | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jun 19, 2013 | clinicaltrials |
| NCT00452634 | Irinotecan/Cisplatin Plus Simvastatin in Extensive Disease-Small Cell Lung Cancer (ED-SCLC) | completed | Phase 2 | 62 | National Cancer Center, KoreaOTHER_GOV | 1 | Jun 19, 2013 | clinicaltrials |
| NCT00027638 | Thalidomide in Treating Patients With Metastatic Neuroendocrine Tumors | completed | Phase 2 | — | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jun 18, 2013 | clinicaltrials |
| NCT00091182 | Oxaliplatin in Treating Young Patients With Recurrent Solid Tumors That Have Not Responded to Previous Treatment | completed | Phase 2 | 180 | National Cancer Institute (NCI)NIH | 1 | Jun 5, 2013 | clinicaltrials |
| NCT00075439 | Gefitinib in Treating Patients With Progressive Metastatic Neuroendocrine Tumors | completed | Phase 2 | 90 | National Cancer Institute (NCI)NIH | 1 | Jun 4, 2013 | clinicaltrials |
| NCT00079131 | Oblimersen in Treating Patients With Merkel Cell Carcinoma | completed | Phase 2 | 37 | National Cancer Institute (NCI)NIH | 1 | Jun 4, 2013 | clinicaltrials |
| NCT00002470 | Fluorouracil Plus Interferon Alfa in Treating Patients With Advanced Metastatic Carcinoid Tumors | completed | Phase 2 | — | Mid-Atlantic Oncology ProgramOTHER | 1 | May 15, 2013 | clinicaltrials |
| NCT00363051 | Safety/Efficacy of Everolimus in Adults With Advanced Pancreatic Neuroendocrine Cancer Not Responsive to Chemotherapy | completed | Phase 2 | 160 | Novartis PharmaceuticalsINDUSTRY | 11 | May 10, 2013 | clinicaltrials |
| NCT00137774 | Bevacizumab in Combination With Temozolomide in Patients With Neuroendocrine Tumors | completed | Phase 2 | 34 | Dana-Farber Cancer InstituteOTHER | 1 | Apr 9, 2013 | clinicaltrials |
| NCT00951613 | A Study of NK012 in Patients With Relapsed Small Cell Lung Cancer | completed | Phase 2 | 72 | Nippon Kayaku Co., Ltd.INDUSTRY | 1 | Mar 20, 2013 | clinicaltrials |
| NCT00284154 | Vinflunine in the Treatment of Patients With Relapsed Extensive Small Cell Lung Cancer | completed | Phase 2 | 51 | SCRI Development Innovations, LLCOTHER | 1 | Mar 13, 2013 | clinicaltrials |
| NCT00028028 | CCI-779 in Treating Patients With Extensive-Stage Small Cell Lung Cancer | completed | Phase 2 | 80 | National Cancer Institute (NCI)NIH | 1 | Feb 28, 2013 | clinicaltrials |
| NCT00068783 | S0331: Imatinib Mesylate in Treating Patients With Metastatic or Unresectable Merkel Cell Cancer | completed | Phase 2 | 40 | National Cancer Institute (NCI)NIH | 1 | Feb 28, 2013 | clinicaltrials |
| NCT00251316 | Effect of Lithium Carbonate on Low-Dose Radioiodine Therapy in Early Thyroid Cancer | completed | Phase 2 | 34 | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)NIH | 1 | Feb 4, 2013 | clinicaltrials |
| NCT00017199 | PS-341 in Treating Patients With Metastatic Neuroendocrine Tumors | completed | Phase 2 | — | Ohio State University Comprehensive Cancer CenterOTHER | 1 | Jan 31, 2013 | clinicaltrials |
| NCT00305942 | Topotecan and Carboplatin in the First-Line Treatment of Patients With Extensive Stage Small Cell Lung Cancer | completed | Phase 2 | 61 | SCRI Development Innovations, LLCOTHER | 1 | Jan 31, 2013 | clinicaltrials |
| NCT00055809 | Bevacizumab and PEG-Interferon Alfa-2b in Treating Patients With Metastatic or Unresectable Carcinoid Tumors | completed | Phase 2 | 44 | National Cancer Institute (NCI)NIH | 1 | Jan 23, 2013 | clinicaltrials |
| NCT00042978 | Carboplatin and Etoposide With or Without Oblimersen Sodium in Treating Patients With Extensive Stage Small Cell Lung Cancer | completed | Phase 2 | 55 | National Cancer Institute (NCI)NIH | 1 | Jan 14, 2013 | clinicaltrials |
| NCT00294190 | Higher Dose Weekly Topotecan In The Treatment Of Patients With Extensive Stage Small-Cell Lung Cancer | completed | Phase 2 | 38 | SCRI Development Innovations, LLCOTHER | 1 | Dec 10, 2012 | clinicaltrials |
| NCT00003549 | S9716: Combination Chemotherapy in Treating Patients With Merkel Cell Cancer | completed | Phase 2 | 80 | SWOG Cancer Research NetworkNETWORK | 1 | Oct 8, 2012 | clinicaltrials |
| NCT00434109 | Phase II Study of Sunitinib Malate Following Hepatic Artery Embolization | completed | Phase 2 | 39 | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 1 | Sep 14, 2012 | clinicaltrials |
| NCT00353015 | Irinotecan and Cisplatin for High Grade Neuroendocrine Carcinoma of the Gastrointestinal Tract | completed | Phase 2 | 21 | M.D. Anderson Cancer CenterOTHER | 1 | Aug 2, 2012 | clinicaltrials |
| NCT00065429 | Safety Study Using Weekly Infusions of BB-10901 in Patients With Small Cell Lung Cancer | completed | Phase 1 / Phase 2 | 64 | ImmunoGen, Inc.INDUSTRY | 1 | Jul 18, 2012 | clinicaltrials |
| NCT00004910 | Endoscopic Placement of Metal Stents in Treating Patients With Cancer- Related Duodenal Obstruction | completed | Phase 1 / Phase 2 | — | Northwestern UniversityOTHER | 1 | Jun 6, 2012 | clinicaltrials |
| NCT00004911 | Endoscopic Placement of Metal Stent in Patients With Cancer-Related Bowel Obstruction | completed | Phase 1 / Phase 2 | — | Northwestern UniversityOTHER | 1 | Jun 6, 2012 | clinicaltrials |
| NCT00088595 | Study Evaluating SOM230 in Patients With Metastatic Carcinoid Tumors | completed | Phase 2 | 45 | Novartis PharmaceuticalsINDUSTRY | 1 | Jun 4, 2012 | clinicaltrials |
| NCT00698516 | Study of Oral Topotecan With Bevacizumab for Recurrent Small Cell Lung Cancer | completed | Phase 2 | 50 | GlaxoSmithKlineINDUSTRY | 1 | Mar 27, 2012 | clinicaltrials |
| NCT00019786 | Isolated Hepatic Perfusion With Melphalan in Treating Patients With Primary Unresectable Liver Cancer or Liver Metastases | completed | Phase 2 | 67 | National Institutes of Health Clinical Center (CC)NIH | 1 | Mar 23, 2012 | clinicaltrials |
| NCT00324012 | Trial With Taxotere and Cisplatin in Non-operable Adrenocortical Carcinoma | completed | Phase 2 | 19 | Rigshospitalet, DenmarkOTHER | 1 | Feb 22, 2012 | clinicaltrials |
| NCT00046787 | Efficacy and Safety Study of OSI-211 (Liposomal Lurtotecan) to Treat Recurrent Small Cell Lung Cancer | completed | Phase 2 | 47 | Astellas Pharma IncINDUSTRY | 2 | Oct 20, 2011 | clinicaltrials |
| NCT00663429 | Extension Study of the Safety and Efficacy of Atiprimod Treatment in Neuroendocrine Carcinoma | completed | Phase 2 | 10 | Callisto PharmaceuticalsINDUSTRY | 1 | Aug 31, 2011 | clinicaltrials |
| NCT00590343 | Safety and Efficacy Study of PTK787/ZK222584 to Treat Metastatic Neuroendocrine Tumors(PTK787) | completed | Phase 2 | 23 | Louisiana State University Health Sciences Center in New OrleansOTHER | 1 | Jun 29, 2011 | clinicaltrials |
| NCT00780663 | Quarfloxin in Patients With Low to Intermediate Grade Neuroendocrine Carcinoma | completed | Phase 2 | 25 | Cylene PharmaceuticalsINDUSTRY | 1 | Jun 15, 2011 | clinicaltrials |
| NCT00317200 | A Study of Paclitaxel Plus Bevacizumab in Patients With Chemosensitive Relapsed Small Cell Lung Cancer | completed | Phase 2 | 34 | Hoosier Cancer Research NetworkOTHER | 1 | May 2, 2011 | clinicaltrials |
| NCT00403403 | A Study of Bevacizumab in Previously Untreated Extensive-Stage Small Cell Lung Cancer (SALUTE) | completed | Phase 2 | 102 | Genentech, Inc.INDUSTRY | 0 | Apr 29, 2011 | clinicaltrials |
| NCT00005049 | Combination Chemotherapy in Treating Patients With Stage III Ovarian Epithelial Cancer or Gastrointestinal Cancer | completed | Phase 2 | 45 | NYU Langone HealthOTHER | 1 | Apr 6, 2011 | clinicaltrials |
| NCT00156286 | Gleevec Maintenance Therapy After Induction Irinotecan and Cisplatin in Patients With C-Kit Positive Extensive SCLC | completed | Phase 2 | 20 | University of Michigan Rogel Cancer CenterOTHER | 1 | Nov 16, 2010 | clinicaltrials |
| NCT01222936 | LBH Phase II in Small Cell Lung Cancer (SCLC) | completed | Phase 2 | 21 | Southern Europe New Drug OrganizationOTHER | 2 | Oct 18, 2010 | clinicaltrials |
| NCT00397293 | Study of AT-101 in Combination With Topotecan in Relapsed/Refractory Small Cell Lung Cancer | completed | Phase 1 / Phase 2 | 36 | Ascenta TherapeuticsINDUSTRY | 3 | Aug 24, 2010 | clinicaltrials |
Data updated 23 days agoSource updated May 21, 2014source: clinicaltrials